Literature DB >> 11053069

Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.

H Locht1, T Skogh, A Wiik.   

Abstract

OBJECTIVE: To study the frequency and distribution of antineutrophil cytoplasmic autoantibodies (ANCA) among patients with reactive arthritis (ReA), rheumatoid arthritis (RA), and ulcerative colitis (UC) using different immunological methods.
METHODS: Fifty serum samples from patients with reactive arthritis (26 with acute disease and 24 with chronic disease-that is disease of more than one year) were analysed for ANCA with indirect immunofluorescence, enzyme linked immunosorbent assay (ELISA) with six different neutrophil granule proteins as antigens, and immunoblotting on whole neutrophil extract and extracts of azurophil and specific granules. Thirty serum samples from patients with RA and UC served as controls in ELISA and indirect immunofluorescence.
RESULTS: Sixteen per cent of patients with ReA were positive in immunofluorescence compared with 30% of patients with RA, and 70% of patients with UC. Thirty two per cent of patients with ReA were positive in ELISA. Antibodies directed against lactoferrin occurred in 20%, antibodies against bactericidal permeability increasing protein (BPI), elastase, cathepsin G, myeloperoxidase, and proteinase 3 were found in 8%, 2%, 2%, 8%, and 6%, respectively. Overall, 50% of RA sera and 53% of UC sera were positive in one or more ELISA assays, the corresponding figures for antibodies against individual antigens were for RA 7%, 3%, 0%, 13%, 47%, 17% and for UC 13%, 20%, 0%, 23%, 10%, and 17%. In immunoblotting, bands corresponding to lactoferrin and BPI were recognised in 44% and 22% of ReA sera.
CONCLUSION: Antibodies against neutrophil granule antigens are often found in patients with ReA, primarily among those with chronic disease. The different methods detect various subsets of antibodies, with immunoblotting being the most and immunofluorescence the least sensitive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053069      PMCID: PMC1753037          DOI: 10.1136/ard.59.11.898

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

Review 1.  Pathophysiology of ANCA-associated glomerulonephritis.

Authors:  A C Muller Kobold; Y M van der Geld; P C Limburg; J W Tervaert; C G Kallenberg
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

2.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.

Authors:  E Peen; S Almer; G Bodemar; B O Rydén; C Sjölin; K Tejle; T Skogh
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

3.  Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA).

Authors:  W H Schmitt; E Csernok; B K Flesch; S Hauschild; W L Gross
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

4.  Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques.

Authors:  B E Britigan; D J Hassett; G M Rosen; D R Hamill; M S Cohen
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

5.  Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.

Authors:  M N Marra; C G Wilde; J E Griffith; J L Snable; R W Scott
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

6.  Anti-granulocyte antibodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA, and chemiluminescence techniques.

Authors:  T Skogh; C Dahlgren; K Holmgren; E Peen; O Stendahl
Journal:  Scand J Immunol       Date:  1991-08       Impact factor: 3.487

7.  Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis.

Authors:  I E Coremans; E C Hagen; M R Daha; F J van der Woude; E A van der Voort; C Kleijburg-van der Keur; F C Breedveld
Journal:  Arthritis Rheum       Date:  1992-12

8.  Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  L Halbwachs-Mecarelli; P Nusbaum; L H Noël; D Reumaux; S Erlinger; J P Grünfeld; P Lesavre
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 9.  'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.

Authors:  W L Gross; E Csernok; B K Flesch
Journal:  J Autoimmun       Date:  1993-04       Impact factor: 7.094

10.  Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.

Authors:  N Borregaard; J M Heiple; E R Simons; R A Clark
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

View more
  5 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 2.  B-cell depletion in Wegener's granulomatosis.

Authors:  Claas H Hinze; Robert A Colbert
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 10.817

Review 3.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  Target antigens for perinuclear antineutrophil cytoplasmic antibodies in Iranian patients with ulcerative colitis.

Authors:  Ali Bahari; Mahmoud Aarabi; Mehdi Hedayati; Ali Jarollahi; Farzad Firouzi; Rahim Aghazadeh; Mohammad Reza Zali; Zohreh Bari; Mohammad Hashemi; Abbas Esmaeilzadeh; Ali Mokhtarifar; Azita Ganji
Journal:  Middle East J Dig Dis       Date:  2014-10

Review 5.  Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases.

Authors:  Kallirroi S Kyriakidi; Vasileios E Tsianos; Evaggelos Karvounis; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2016-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.